Pillar · Mitochondrial biology
Mitochondrial Peptide Research
Two distinct groups sit under this heading. Mitochondrial-derived peptides are encoded within mitochondrial DNA itself and act as signalling molecules between the mitochondrion and the nucleus. Mitochondria-targeting peptides are synthetic compounds designed to accumulate in the inner mitochondrial membrane. They are studied for different reasons and have very different evidence positions.
Evidence position
Emerging human research
Research evidence, established clinical evidence and regulatory approval are three different things. This page distinguishes them throughout and does not present research compounds as approved treatments.
Mitochondrial-derived peptides
Small open reading frames within mitochondrial DNA encode short peptides — humanin, MOTS-c and the SHLP family among them — that appear to participate in retrograde signalling to the nucleus. MOTS-c has been studied in relation to AMPK activation, glucose handling and exercise adaptation, largely in cell and rodent systems with a small number of human observational measurements.
Mitochondria-targeting synthetic peptides
SS-31, also known as elamipretide, binds cardiolipin in the inner mitochondrial membrane. Cardiolipin organises the respiratory supercomplexes, and its remodelling is a recognised feature of mitochondrial dysfunction. This compound has progressed into registered human clinical trials in primary mitochondrial disease, which places it further along the evidence hierarchy than most peptides on this site — with mixed trial results that should be read directly rather than summarised second-hand.
Why mitochondrial endpoints are hard to measure
Meaningful mitochondrial research requires functional measures — respirometry on isolated mitochondria or permeabilised fibres, ATP production rates, membrane potential, reactive oxygen species production. Studies reporting only mitochondrial content markers, or subjective energy outcomes, do not demonstrate improved mitochondrial function.
Compounds studied in this area
| Compound | What it is | Evidence tier |
|---|---|---|
| MOTS-c | A 16-amino-acid mitochondrial-derived peptide studied in metabolic and exercise physiology. | Early laboratory research |
| SS-31 / Elamipretide | A cardiolipin-binding tetrapeptide evaluated in registered human trials. | Emerging human research |
| Humanin | The first-described mitochondrial-derived peptide, studied in cytoprotection models. | Early laboratory research |
Comparisons in this cluster
Key takeaways
- Two distinct groups sit under this heading. Mitochondrial-derived peptides are encoded within mitochondrial DNA itself and act as signalling molecules between the mitochondrion and the nucleus. Mitochondria-targeting peptides are synthetic compounds designed to accumulate in the inner mitochondrial membrane. They are studied for different reasons and have very different evidence positions.
- Overall evidence position for this topic: emerging human research.
- Findings in cells or animals are hypotheses about humans, never demonstrations in humans.
- Nothing on this page is medical advice, a protocol, or a dosing recommendation.
Frequently asked questions
What is a mitochondrial-derived peptide?
A short peptide encoded by the mitochondrial genome rather than nuclear DNA, which acts as a signalling molecule between mitochondria and the cell nucleus.
Has SS-31 been tested in humans?
Yes. Elamipretide has been evaluated in registered clinical trials in mitochondrial disease, with mixed results across endpoints.
Continue reading
Related research hubs
Peptide Science
How peptides are built, how they signal, how they are synthesised and how they are studied — the foundational science behind every other topic on this site.
Longevity & Anti-Aging
The measurable biology of ageing — telomere dynamics, senescence, mitochondrial decline — and the peptides studied against those endpoints, with evidence tiers.
Peptide Research & Clinical Trials
How peptide research is conducted and graded — trial phases, endpoints, evidence hierarchy, and how to read a peptide study without over-reading it.
About this page
Written and reviewed by the Peptide Intel Hub Editorial Team. Last reviewed 8 September 2026.
Scientific disclaimer: this page is educational and does not constitute medical advice. Research compounds referenced here are not approved treatments. See our research disclaimer.